期刊文献+

Experience of Using the Recombinant Human Superoxide Dismutase Drug in Neurological and Ophthalmological Practice

Experience of Using the Recombinant Human Superoxide Dismutase Drug in Neurological and Ophthalmological Practice
下载PDF
导出
摘要 Recsod? has been used for treating epilepsy and ophthalmological disease. Oxidative stress has been demonstrated to be a pathogenic chain of these diseases. Parameters of pro- and antioxidant systems were studied in all the patients treated. Recsod? drug was shown to produce positive effect in all the patients. Improvement of patients’ clinical condition correlated with an increase in antioxidant activities. Antioxidants, in particular, the recombinant human SOD drug, proved to be effective in treatment of some neurological and ophthalmological diseases. Recsod? has been used for treating epilepsy and ophthalmological disease. Oxidative stress has been demonstrated to be a pathogenic chain of these diseases. Parameters of pro- and antioxidant systems were studied in all the patients treated. Recsod? drug was shown to produce positive effect in all the patients. Improvement of patients’ clinical condition correlated with an increase in antioxidant activities. Antioxidants, in particular, the recombinant human SOD drug, proved to be effective in treatment of some neurological and ophthalmological diseases.
出处 《Open Journal of Medicinal Chemistry》 2014年第2期70-78,共9页 药物化学期刊(英文)
关键词 Superoxide DISMUTASE Oxidative Stress Reactive Oxygen Species Epilepsy AGE-RELATED MACULAR DEGENERATION Superoxide Dismutase Oxidative Stress Reactive Oxygen Species Epilepsy Age-Related Macular Degeneration

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部